PUBLISHER: The Business Research Company | PRODUCT CODE: 1946708
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946708
Oxygen concentrators are devices designed to extract nitrogen and oxygen from the ambient air, delivering pure oxygen to patients. They are primarily employed for providing oxygen to individuals with respiratory diseases.
The primary types of oxygen concentrators are portable and stationary. Portable oxygen concentrators are smaller, more mobile, cost-effective, and easily transportable from one location to another. Different technologies are utilized, including pulse dose, continuous flow, and others. These oxygen concentrators find application in various medical conditions such as chronic obstructive pulmonary disease (COPD), lung cancer, pneumonia, and other respiratory system diseases. They are utilized by hospitals, home care services, and other healthcare settings.
Tariffs are impacting the oxygen concentrators market by increasing costs of imported compressors, electronic control units, sensors, and battery components used in portable and stationary devices. Healthcare providers in North America and Europe are most affected due to dependence on imported medical electronics, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are raising device prices and slowing replacement cycles. However, they are also encouraging domestic assembly, local component sourcing, and innovation in cost-efficient oxygen concentrator designs.
The oxygen concentrators market research report is one of a series of new reports from The Business Research Company that provides oxygen concentrators market statistics, including oxygen concentrators industry global market size, regional shares, competitors with a oxygen concentrators market share, detailed oxygen concentrators market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen concentrators industry. This oxygen concentrators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The oxygen concentrators market size has grown strongly in recent years. It will grow from $2.38 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing prevalence of respiratory disorders, expansion of home healthcare services, rising awareness of oxygen therapy benefits, improved access to medical oxygen devices, growing elderly population.
The oxygen concentrators market size is expected to see strong growth in the next few years. It will grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising investments in home healthcare infrastructure, expansion of portable medical device usage, growing focus on patient mobility solutions, continuous advancements in oxygen separation technologies. Major trends in the forecast period include increasing demand for portable oxygen concentrators, rising adoption of home-based oxygen therapy, growing integration of smart oxygen monitoring features, expansion of lightweight and compact device designs, enhanced focus on energy-efficient oxygen delivery.
The rising prevalence of respiratory disorders worldwide is expected to support continued growth in the oxygen concentrators market. Respiratory disorders include chronic and acute conditions such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and post-viral respiratory complications that impair lung function and reduce oxygen saturation levels in the body. The growing burden of these conditions is largely attributed to factors such as increasing air pollution, tobacco consumption, occupational exposure to harmful substances, and the long-term health effects of respiratory infections. As respiratory illnesses become more widespread, demand is increasing for dependable and continuous oxygen therapy solutions used across homecare, clinical, and emergency care environments. For example, in November 2025, the American Lung Association reported that more than 35 million people in the United States are living with chronic lung diseases such as asthma and COPD. In addition, approximately 226,650 individuals are projected to be diagnosed with lung cancer in 2025, while acute respiratory diseases may impact up to 44 million people. Consequently, the growing prevalence of respiratory disorders is contributing to increased adoption of oxygen concentrators.
Leading companies operating in this space are increasingly focusing on technological innovation, including artificial intelligence integration and the development of cost-effective portable devices, to enhance product performance and accessibility. Artificial intelligence-enabled and low-cost portable solutions are designed to provide efficient monitoring and oxygen delivery, particularly in point-of-care and remote healthcare settings. In March 2024, Drive DeVilbiss Healthcare, a United States-based manufacturer of durable medical equipment, in collaboration with Sanrai International, introduced the PulmO2 10L Oxygen Concentrator. The device is engineered for high energy efficiency and durability, making it suitable for use in demanding clinical environments. The PulmO2 is intended to deliver consistent oxygen therapy, especially in resource-constrained settings, while significantly reducing energy consumption compared to conventional 10-liter concentrators.
In 2025, Yuwell Medical, one of the world's leading manufacturers of oxygen concentrators, entered into a strategic partnership with Inogen to strengthen innovation capabilities and expand global reach in the respiratory care segment. Through this collaboration, both companies aim to enhance device technology by working more closely across key operational areas. By combining their technological expertise, brand strength, and regional presence, the partnership focuses on international distribution, trademark licensing, joint research and development initiatives, and supply chain optimization. These efforts are intended to accelerate technology upgrades and improve global access to advanced oxygen concentrator solutions. Inogen is a United States-based manufacturer specializing in portable oxygen concentrators.
Major companies operating in the oxygen concentrators market are Inogen Inc, Koninklijke Philips N.V, Invacare Corporation, CAIRE Inc, O2 Concepts LLC, Nidek Medical Products Inc., Precision Medical Inc, Drive Devilbiss Healthcare Ltd, 3B Medical Inc, BPL, Evox Oxygen Concentrators, Nanjing Everich Medicare Import & Export Co. Ltd, AngelBiss Medical Technology Co. Ltd, Hefei DX Medical Co. Ltd, Longfian Scitech Co. Ltd, Pure O2, Heinen + Lowenstein GmbH & Co. KG, DeVilbiss Healthcare GmbH, ResMed, AirSep Corporation, Sequal Technologies Inc
North America was the largest region in the oxygen concentrators market in 2025. Europe was the second-largest region in the oxygen concentrators market. The regions covered in the oxygen concentrators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the oxygen concentrators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The oxygen concentrators market consists of sales of Compressed gas systems, Portable oxygen concentrators (POCs), and Liquid oxygen systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Oxygen Concentrators Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses oxygen concentrators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for oxygen concentrators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oxygen concentrators market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.